IMPACT Therapeutics, Inc. Class H(HK:7630)
HK$9.33+0.21 (+2.30%)
HK:7630
IMPACT Therapeutics, Inc. Class H financials statements
HK$9.33
At close:+0.21 (+2.30%)
Want to see HK:7630 full AI Analyst Report?
IMPACT Therapeutics, Inc. Class H (7630) Income Statement
IMPACT Therapeutics, Inc. Class H Income Statement
Last quarter (Q2 2026), IMPACT Therapeutics, Inc. Class H's total revenue was $15.31M. In Q2, IMPACT Therapeutics, Inc. Class H's net income was $-13.22M. See IMPACT Therapeutics, Inc. Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| $ 5.33M | $ 4.68M | $ 33.27M | |
| $ 4.49M | $ 3.54M | $ 32.14M | |
| $ 36.53M | $ 32.52M | $ 36.14M | |
| Depreciation and Amortization | $ 623.31K | $ 928.35K | $ 1.14M |
| $ -31.42M | $ -26.86M | $ -1.60M | |
| $ -32.04M | $ -28.98M | $ -4.00M | |
| $ -9.19M | $ -6.56M | $ 1.18M | |
| $ -41.23M | $ -35.54M | $ -2.82M | |
| $ -41.23M | $ -35.54M | $ 519.73K | |
| Per Share Metrics | |||
| Basic EPS | $ -0.15 | $ -0.18 | $ 0.00 |
| Diluted EPS | $ -0.15 | $ -0.18 | $ 0.00 |
| Weighted Average Shares Outstanding | 276.17M | 200.51M | 147.44M |
| Weighted Average Shares Outstanding (Diluted) | 276.17M | 200.51M | 147.44M |
Currency in USD

